The role of SARS-CoV-2 immunosuppression and the therapy used to manage COVID-19 disease in the emergence of opportunistic fungal infections: A review

Since December 2019 SARS-CoV-2 infections have affected millions of people worldwide. Along with the increasing number of COVID-19 patients, the number of cases of opportunistic fungal infections among the COVID-19 patients is also increasing. There have been reports of the cases of aspergillosis an...

Descripción completa

Detalles Bibliográficos
Autores principales: Akhtar, Nahid, Khurshid Wani, Atif, Kant Tripathi, Surya, Prakash, Ajit, Amin-ul Mannan, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347179/
https://www.ncbi.nlm.nih.gov/pubmed/35942223
http://dx.doi.org/10.1016/j.crbiot.2022.08.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347179/
https://www.ncbi.nlm.nih.gov/pubmed/35942223
http://dx.doi.org/10.1016/j.crbiot.2022.08.001

Ejemplares similares